• You need to sign in or sign up before continuing.
Close
https://www.healio.com/news/hematology-oncology/20220909/metabolic-imaging-predicts-neoadjuvant-therapy-response-before-pancreatic-cancer-surgery
0
0
44 words
0
Comments
The addition of 18-fluorodeoxyglucose to PET provided significant prognostic benefit in objective assessment of neoadjuvant chemotherapy response among patients with borderline resectable/locally advanced pancreatic cancer.The findings, published in JNCCN &md…
You are the first to view
Create an account or login to join the discussion